BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12195093)

  • 1. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
    Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
    Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability.
    Hasegawa S; Uehara T; Yamaguchi H; Fujino K; Kusuoka H; Hori M; Nishimura T
    J Nucl Med; 1999 Nov; 40(11):1884-92. PubMed ID: 10565785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction.
    Nowak B; Zimny M; Schwarz ER; Kaiser HJ; Schaefer W; Reinartz P; vom Dahl J; Buell U
    Eur J Nucl Med; 2000 Oct; 27(10):1501-8. PubMed ID: 11083539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose.
    Matsunari I; Böning G; Ziegler SI; Nekolla SG; Stollfuss JC; Kosa I; Ficaro EP; Schwaiger M
    J Am Coll Cardiol; 1998 Oct; 32(4):927-35. PubMed ID: 9768713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
    J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
    Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
    Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of myocardial viability following acute myocardial infarction using 201Tl SPECT after thallium-glucose-insulin infusion--comparison with 18F-FDG positron emission tomography.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Oshima S; Taniguchi K; Higuchi K; Seki H; Hatori T; Kurabayashi M; Endo K
    Ann Nucl Med; 2004 Sep; 18(6):463-8. PubMed ID: 15515744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization.
    Bax JJ; Cornel JH; Visser FC; Fioretti PM; Huitink JM; van Lingen A; Sloof GW; Visser CA
    J Nucl Cardiol; 1997; 4(4):302-8. PubMed ID: 9278877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of functional improvement of ischemic myocardium with (123I-BMIPP SPECT and 99mTc-tetrofosmin SPECT imaging: a study of patients with large acute myocardial infarction and receiving revascularization therapy.
    Seki H; Toyama T; Higuchi K; Kasama S; Ueda T; Seki R; Hatori T; Endo K; Kurabayashi M
    Circ J; 2005 Mar; 69(3):311-9. PubMed ID: 15731537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?
    Srinivasan G; Kitsiou AN; Bacharach SL; Bartlett ML; Miller-Davis C; Dilsizian V
    Circulation; 1998 Mar; 97(9):843-50. PubMed ID: 9521332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
    Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET.
    Tian M; Koyama K; Zhang H; Oriuchi N; Higuchi T; Endo K
    Nucl Med Commun; 2003 Apr; 24(4):367-74. PubMed ID: 12673164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical assessment of myocardial viability with a positron coincidence gamma camera using 18F-fluorodeoxyglucose in acute myocardial infarction: comparison with dedicated positron emission tomography and 201Tl single photon emission computed tomography.
    Seki R; Seki H; Toyama T; Koyama K; Endo K; Kurabayashi M
    J Cardiol; 2009 Apr; 53(2):265-71. PubMed ID: 19304132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.
    Fitzgerald J; Parker JA; Danias PG
    J Nucl Cardiol; 2000; 7(4):382-7. PubMed ID: 10958281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
    Maruyama A; Hasegawa S; Paul AK; Xiuli M; Yoshioka J; Maruyama K; Hori M; Nishimura T
    Ann Nucl Med; 2002 Feb; 16(1):25-32. PubMed ID: 11922205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study.
    Soares J; Rodrigues Filho F; Izaki M; Giorgi MC; Catapirra RM; Abe R; Vinagre CG; Cerri GG; Meneghetti JC
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):415-23. PubMed ID: 24253855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.
    Kühl HP; Beek AM; van der Weerdt AP; Hofman MB; Visser CA; Lammertsma AA; Heussen N; Visser FC; van Rossum AC
    J Am Coll Cardiol; 2003 Apr; 41(8):1341-8. PubMed ID: 12706930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.